Chikungunya fever in French Polynesia
'Saturday, 18 October, 2014'
Enterovirus respiratory disease in North America
'Friday, 17 October, 2014'
Locally transmitted dengue increases in Tokyo
'Sunday, 28 September, 2014'
Dengue in Guandong province of China
'Thursday, 25 September, 2014'
Mosquito Borne Virus Diseases in Pacific Islands
'Saturday, 20 September, 2014'
Measles in Vietnam
'Monday, 8 September, 2014'
Chikungunya infection in American Samoa
'Monday, 28 July, 2014'
Whooping cough in California
'Sunday, 29 June, 2014'
Dengue risk in France
'Wednesday, 4 June, 2014'
Recurrence of parasitic muscle disease in offshore islands, Malaysia
'Sunday, 1 June, 2014'
Pre Travel
Whilst Away
Upon Return
Business Travel
School & Sport Groups
  Select Your Region
  
Contact Us
WHO News

WHO News

WHO updates personal protective equipment guidelines for Ebola response

Fri, 31 Oct 2014 09:00:00 GMT
As part of WHO’s commitment to safety and protection of healthcare workers and patients from transmission of Ebola virus disease, WHO has conducted a formal review of personal protective equipment (PPE) guidelines for healthcare workers and is updating its guidelines in context of the current outbreak.

These updated guidelines aim to clarify and standardize safe and effective PPE options to protect health care workers and patients, as well as provide information for procurement of PPE stock in the current Ebola outbreak. The guidelines are based on a review of evidence of PPE use during care of suspected and confirmed Ebola virus disease patients.
Top of Page

WHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital

Tue, 28 Oct 2014 08:00:00 GMT
The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). This marks the latest step towards bringing safe and effective Ebola vaccines for testing and implementation as quickly as possible.

Approval means that the vaccine can be used on approximately 120 individuals in Lausanne. The trial, which is receiving support from WHO, is the latest in a series of trials that are ongoing in Mali, the United Kingdom, and the United States.
Top of Page

WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine

Fri, 24 Oct 2014 09:00:00 GMT
WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic.

WHO was called upon by all parties to ensure coordination between the various actors.
Top of Page

Mali confirms its first case of Ebola

Fri, 24 Oct 2014 01:27:00 GMT
Mali’s Ministry of Health has confirmed the country’s first case of Ebola virus disease. The Ministry received positive laboratory results, from PCR testing, on Thursday and informed WHO immediately. In line with standard procedures, samples are being sent to a WHO-approved laboratory for further testing and diagnostic work.

In telephone conversation on Thursday night, health officials gave WHO the following details about the case, which is currently undergoing intense investigation.
Top of Page

Statement on the 3rd meeting of the IHR Emergency Committee regarding the 2014 Ebola outbreak in West Africa

Thu, 23 Oct 2014 08:18:00 GMT
The third meeting of the Emergency Committee convened by the WHO Director-General under the IHR 2005 regarding the 2014 Ebola virus disease (EVD, or “Ebola”) outbreak in West Africa was conducted with members and advisors of the Emergency Committee on Wednesday, 22 October 2014, from 13:00 to 17:10 CET.

This meeting was convened in advance of the 3-month date of the expiration of the temporary recommendations issued on 8 August 2014 and their extension on 22 September 2014, owing to the increase in numbers of cases in Guinea, Liberia, and Sierra Leone, and the new exportation of cases resulting in limited transmission in Spain and United States of America.
Top of Page


Top of Page

The Travel Doctor health alerts



The Travel Doctor TMVC Health Alerts

Chikungunya fever in French Polynesia

Saturday, 18 October, 2014

Top of Page

Enterovirus respiratory disease in North America

Friday, 17 October, 2014

Top of Page

Locally transmitted dengue increases in Tokyo

Sunday, 28 September, 2014

Top of Page

Dengue in Guandong province of China

Thursday, 25 September, 2014

Top of Page

Mosquito Borne Virus Diseases in Pacific Islands

Saturday, 20 September, 2014

Top of Page

Measles in Vietnam

Monday, 8 September, 2014

Top of Page

Chikungunya infection in American Samoa

Monday, 28 July, 2014

Top of Page

Whooping cough in California

Sunday, 29 June, 2014

Top of Page

Dengue risk in France

Wednesday, 4 June, 2014

Top of Page

Recurrence of parasitic muscle disease in offshore islands, Malaysia

Sunday, 1 June, 2014

Top of Page


Top of Page
Top of Page
WHO updates personal protective equipment guidelines for Ebola response
'Fri, 31 Oct 2014 09:00:00 GMT'
WHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital
'Tue, 28 Oct 2014 08:00:00 GMT'
WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine
'Fri, 24 Oct 2014 09:00:00 GMT'
Mali confirms its first case of Ebola
'Fri, 24 Oct 2014 01:27:00 GMT'
Statement on the 3rd meeting of the IHR Emergency Committee regarding the 2014 Ebola outbreak in West Africa
'Thu, 23 Oct 2014 08:18:00 GMT'
When to Seek Advice / Vaccination
How Long Do They Last?
What Are The Likely Side Effects?
Will They Weaken My Immune System?
What if I Have a Cold?
Can I Drink Alcohol After Vaccines?
Travel Health Advisory Report
Privacy & CopyrightCreditsContact Us